QQQ na na (na)
DIA na na (na)
SPY na na (na)
TLT na na (na)
GLD na na (na)
$ na
-- x --
-- x --
-- - --
na - na
0
na
na
na
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 craig-hallum-maintains-hold-on-accelerate-diagnostics-lowers-price-target-to-1

Craig-Hallum analyst Alexander Nowak maintains Accelerate Diagnostics (NASDAQ:AXDX) with a Hold and lowers the price target ...

 accelerate-diagnostics-q4-eps-089-misses-062-estimate-sales-303m-miss-345m-estimate

Accelerate Diagnostics (NASDAQ:AXDX) reported quarterly losses of $(0.89) per share which missed the analyst consensus estimate...

 earnings-scheduled-for-march-28-2024

Companies Reporting Before The Bell • Universal Stainless (NASDAQ:USAP) is expected to report quarterly earnings at $0.32 per ...

 why-transcode-therapeutics-shares-are-trading-lower-by-over-24-here-are-other-stocks-moving-in-fridays-mid-day-session

Shares of TransCode Therapeutics, Inc. (NASDAQ: RNAZ) fell sharply during Friday’s session. TransCode Therapeutics priced a 5,...

 why-accelerate-diagnostics-axdx-stock-is-down-38

Accelerate Diagnostics shares are trading lower by 38% during Friday's session. The company priced an underwritten public o...

 us-stocks-higher-schlumberger-earnings-beat-estimates

U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 50 points on Friday. Following the market o...

 accelerate-diagnostics-announces-pricing-of-15m-public-offering-and-private-placement-the-public-offering-price-for-each-unit-is-150-and-the-public-offering-price-for-each-pre-funded-unit-is-149

Accelerate Diagnostics, Inc. (NASDAQ:AXDX) (the "Company") today announced the pricing of an underwritten public offeri...

 why-accelerate-diagnostics-axdx-stock-hit-a-new-52-week-low-today

Accelerate Diagnostics shares are trading lower by 23.2% Tuesday morning. The company announced the initiation of a proposed un...

 accelerate-diagnostics-has-launched-a-proposed-underwritten-public-offering-of-45m-each-consisting-of-one-share-of-common-stock-and-one-warrant-to-purchase-one-share-of-common-stock-terms-not-disclosed

The Company expects to grant the underwriters a 30-day option to purchase up to an additional 675,000 shares of common stock an...

 accelerate-diagnostics-announces-certain-preliminary-q4-and-fy23-results-fy23-preliminary-revenue-was-121m-vs-128m-yoy-ended-the-year-with-134m-in-cash-and-cash-equivalents

Accelerate Diagnostics, Inc. (NASDAQ:AXDX) (Accelerate), an in vitro diagnostics company dedicated to providing services that i...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION